I just got their email... Maybe good news? Personally the "video testimonials" (just '2') that they've shown are pretty suspect... But I'll keep the door open...
-------------------------------------------
IMPORTANT: On December 20, 2022, Dr. Jacobs, Viktoryia Montano, and I, will report on the status of the first Parkinson's disease patients dosed with FGF-1 back in May 2022. Data will be presented at this webinar on the medical outcomes with the patients, including safety, cognitive and motor skill changes seen at the 6-month point in the follow-up timeline.
The Zoom webinar will be held at 4:00 PM Pacific time (GMT -08:00), 7:00 PM Eastern time. If you are interested in viewing the webinar, please register at:
us02web.zoom.us/webinar/reg...
Thousands of people are following our progress to treat sufferers of Parkinson's disease with our intranasal formulation of FGF-1. This webinar will provide an update on our journey of discovery with the latest data on how our patients are progressing.
Introduction: This December 2022 Update has a lot of information in it, and I hope it will be of interest to you. We have exciting news on both the medical front and the business front, which we will discuss below.